WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CoxCEO;Pres2026-09-085,658$18.88
$106.82kSell
Douglas KerrMed2026-09-081,290$18.88
$24.36kSell
Johanna FriedlnadererCCO2026-09-08185$18.88
$3.49kSell
Douglas KerrMed2026-09-043,745$24.35
$91.19kSell
Johanna FriedlnadererCCO2026-09-04900$24.35
$21.92kSell
Jason P. RhodesDirector2026-08-141,359,674$25.00
$33.99MSell
Jason P. RhodesDirector2026-08-14478,377$25.00
$11.96MSell
Jason P. RhodesDirector2026-08-14322,465$25.00
$8.06MSell
Johanna FriedlnadererCCO2026-08-13226$26.28
$5.94kSell
Douglas KerrMed2026-08-131,556$26.28
$40.89kSell

1 of 13

DYN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dirk Kersten3.98%7,435,052$135.39MInsider
Atlas Venture Fund XI LP3.51%6,562,578$119.50MInsider
Forbion Capital Fund IV Cooperatief Ua3.28%6,131,079$111.65MInsider
VV Manager II LLC1.59%2,960,046$53.90MInsider
Ra Capital Management LP1.50%2,805,045$51.08MInsider
Atlas Venture Opportunity Fund II LP1.36%2,543,366$46.31MInsider
Atlas Venture Opportunity Fund I LP1.23%2,306,079$41.99MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.86%1,608,785$29.30MInsider
Logos Global Management LP0.81%1,504,392$27.39MInsider
Cureduchenne Ventures LLC0.32%602,972$10.98MInsider

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN0.10%20.12%Net SellingNet Selling
DNLI0.10%57.28%Net SellingNet Selling
ABCL0.04%44.49%Net BuyingNet Buying
TARS0.11%39.12%Net SellingNet Selling
VCYT0.11%53.43%Net SellingNet Selling
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 0.10% institutional shareholders, 20.12% Dyne Therapeutics insiders, and 79.78% retail investors. Dirk Kersten is the largest individual Dyne Therapeutics shareholder, owning 7.44M shares representing 3.98% of the company. Dirk Kersten's Dyne Therapeutics shares are currently valued at $135.39M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.